# RANOLAZINE

NDC: 72319-021
Generic name: RANOLAZINE
Labeler / Manufacturer: i3 Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20220615

FDA application: ANDA213517

## Active ingredients

- RANOLAZINE: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72319-021"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72319-021
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de3185bf-448a-15f7-e053-2995a90a9a2e